Inhibitors of Akt activity
US8614221B2 · kind B2 · utility
1Cited by
5References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 2010 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Aug 26, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The instant invention provides for substituted fused naphthyridine derivatives that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.